US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
TW366342B
(en)
*
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
USRE38968E1
(en)
|
1992-07-28 |
2006-02-07 |
Eli Lilly And Company |
Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
|
USRE39049E1
(en)
|
1992-07-28 |
2006-03-28 |
Eli Lilly And Company |
Methods for inhibiting bone loss
|
US6395494B1
(en)
|
1993-05-13 |
2002-05-28 |
Neorx Corporation |
Method to determine TGF-β
|
US5770609A
(en)
|
1993-01-28 |
1998-06-23 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6251920B1
(en)
|
1993-05-13 |
2001-06-26 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6197789B1
(en)
|
1995-06-07 |
2001-03-06 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
|
US6319914B1
(en)
|
1993-11-05 |
2001-11-20 |
Apollo Biopharmaceuticals, Inc. |
Cytoprotective effect of polycyclic phenolic compounds
|
US5554601A
(en)
*
|
1993-11-05 |
1996-09-10 |
University Of Florida |
Methods for neuroprotection
|
US5578613A
(en)
*
|
1993-12-21 |
1996-11-26 |
Eli Lilly And Company |
Methods for inhibiting weight gain or inducing weight loss
|
US6417198B1
(en)
|
1993-12-21 |
2002-07-09 |
Eli Lilly And Company |
Methods of inhibiting CNS problems in post-menopausal women
|
US5478847A
(en)
|
1994-03-02 |
1995-12-26 |
Eli Lilly And Company |
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
US5972383A
(en)
*
|
1994-03-02 |
1999-10-26 |
Eli Lilly And Company |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
|
US5811120A
(en)
*
|
1994-03-02 |
1998-09-22 |
Eli Lilly And Company |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
|
US5502074A
(en)
*
|
1994-08-22 |
1996-03-26 |
Eli Lilly And Company |
Benzothiophenes for bone healing and fracture repair
|
JP2001503728A
(ja)
*
|
1994-09-09 |
2001-03-21 |
ザ、プロクター、エンド、ギャンブル、カンパニー |
骨粗鬆症治療用のエストロゲン及び副甲状腺ホルモン
|
US6562862B1
(en)
|
1994-10-20 |
2003-05-13 |
Eli Lilly And Company |
Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
|
EP0724879A2
(en)
*
|
1995-02-06 |
1996-08-07 |
Eli Lilly And Company |
2-Phenyl-3-azoylbenzothiopenes for inhibiting effects of IL-6
|
JP3263598B2
(ja)
*
|
1995-11-01 |
2002-03-04 |
有限会社ドット |
経鼻吸収用生理活性ペプチド組成物
|
AU761274B2
(en)
*
|
1996-01-29 |
2003-05-29 |
Schering Aktiengesellschaft |
Pharmaceutical combination preparation that consists of LHRH-analogues and antiestrogens for treating gynecological disorders
|
IL120270A0
(en)
*
|
1996-02-28 |
1997-06-10 |
Pfizer |
Combination therapy to treat osteoporosis
|
HN1996000101A
(es)
|
1996-02-28 |
1997-06-26 |
Inc Pfizer |
Terapia combinada para la osteoporosis
|
US6117911A
(en)
*
|
1997-04-11 |
2000-09-12 |
Neorx Corporation |
Compounds and therapies for the prevention of vascular and non-vascular pathologies
|
SE9702401D0
(sv)
|
1997-06-19 |
1997-06-19 |
Astra Ab |
Pharmaceutical use
|
AU8356198A
(en)
*
|
1997-07-22 |
1999-02-16 |
Chugai Seiyaku Kabushiki Kaisha |
Dental remedies containing pth
|
CA2306344A1
(en)
*
|
1997-10-14 |
1999-04-22 |
Masahiko Sato |
Method of building and maintaining bone
|
US6054446A
(en)
|
1997-12-24 |
2000-04-25 |
Sri International |
Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
|
US20040186185A1
(en)
*
|
1998-05-07 |
2004-09-23 |
Steiner Mitchell S. |
Method for treatment and chemoprevention of prostate cancer
|
US20040033950A1
(en)
*
|
2000-09-26 |
2004-02-19 |
Hock Janet M. |
Method of increasing bone toughness and stiffness and reducing fractures
|
AU6510999A
(en)
*
|
1998-10-07 |
2000-04-26 |
Board Of Trustees Of The University Of Arkansas, The |
Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof
|
WO2000028982A2
(en)
|
1998-11-19 |
2000-05-25 |
The Board Of Trustees For The University Of Arkansas |
Increasing bone strength with selected bisphosphonates
|
US20040214889A1
(en)
*
|
1999-07-31 |
2004-10-28 |
Smithkline Beecham Corporation |
Calcilytic compounds
|
CA2387693A1
(en)
*
|
1999-09-20 |
2001-03-29 |
Eli Lilly And Company |
Method for monitoring treatment with a parathyroid hormone
|
ATE314822T1
(de)
*
|
2000-10-10 |
2006-02-15 |
Microchips Inc |
Mikrochip-reservoir-vorrichtungen mit drahtloser übertragung von energie und daten
|
US20030216358A1
(en)
*
|
2001-07-05 |
2003-11-20 |
Muchmore Douglas Boyer |
Method for enhancing bone mineral density gain
|
US20050080143A1
(en)
*
|
2001-11-29 |
2005-04-14 |
Steiner Mitchell S. |
Treatment of androgen-deprivation induced osteoporosis
|
US20080249183A1
(en)
*
|
2001-11-29 |
2008-10-09 |
Steiner Mitchell S |
Treatment of androgen-deprivation induced osteoporosis
|
US20060269611A1
(en)
*
|
2001-11-29 |
2006-11-30 |
Steiner Mitchell S |
Prevention and treatment of androgen-deprivation induced osteoporosis
|
US20040214898A1
(en)
*
|
2001-11-29 |
2004-10-28 |
Steiner Mitchell S. |
Methods for treating hot flashes
|
US20070197664A1
(en)
*
|
2001-11-29 |
2007-08-23 |
Steiner Mitchell S |
Prevention and treatment of androgen-deprivation induced osteoporosis
|
JP2005515988A
(ja)
*
|
2001-11-29 |
2005-06-02 |
ジーティーエックス・インコーポレイテッド |
骨粗鬆症を引き起こすアンドロゲン欠乏の予防及び治療
|
US7247609B2
(en)
*
|
2001-12-18 |
2007-07-24 |
Universitat Zurich |
Growth factor modified protein matrices for tissue engineering
|
CA2489098A1
(en)
*
|
2002-06-13 |
2003-12-24 |
Wyeth |
Bazedoxifene treatment regimens
|
JP3887588B2
(ja)
*
|
2002-08-30 |
2007-02-28 |
株式会社リガク |
X線回折による応力測定法
|
WO2004022033A1
(en)
*
|
2002-09-04 |
2004-03-18 |
Microchips, Inc. |
Method and device for the controlled delivery of parathyroid hormone
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US20060106010A1
(en)
*
|
2003-05-27 |
2006-05-18 |
Black Larry J |
Methods for inhibiting bone loss
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
PA8621401A1
(es)
*
|
2004-01-13 |
2006-07-03 |
Wyeth Corp |
Tratamiento de la osteoporosis relacionada con la terapia de inhibidor de aromatasa
|
CA2566032A1
(en)
|
2004-05-13 |
2005-12-01 |
Alza Corporation |
Apparatus and method for transdermal delivery of parathyroid hormone agents
|
US7648965B2
(en)
*
|
2004-05-14 |
2010-01-19 |
Unigene Laboratories Inc. |
Method for fostering bone formation and preservation
|
US7531518B2
(en)
*
|
2004-05-14 |
2009-05-12 |
Unigene Laboratories Inc. |
Method for fostering bone formation and preservation
|
US8575101B2
(en)
|
2005-01-06 |
2013-11-05 |
Kuros Biosurgery Ag |
Supplemented matrices for the repair of bone fractures
|
WO2006073711A2
(en)
*
|
2005-01-06 |
2006-07-13 |
Kuros Biosurgery Ag |
Use of a matrix comprising a contrast agent in soft tissues
|
EP1843783B1
(en)
*
|
2005-01-25 |
2012-05-30 |
MicroCHIPS, Inc. |
Control of drug release by transient modification of local microenvironments
|
US20080076975A1
(en)
*
|
2005-01-25 |
2008-03-27 |
Microchips, Inc. |
Method and implantable device with reservoir array for pre-clinical in vivo testing
|
US20060293667A1
(en)
*
|
2005-05-19 |
2006-12-28 |
Agnes Vignery |
Bone implant device and methods of using same
|
US7691105B2
(en)
*
|
2005-09-26 |
2010-04-06 |
Depuy Spine, Inc. |
Tissue augmentation, stabilization and regeneration technique
|
US20070088436A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Matthew Parsons |
Methods and devices for stenting or tamping a fractured vertebral body
|
US20070173447A1
(en)
*
|
2005-10-25 |
2007-07-26 |
Nastech Pharmaceutical Company Inc. |
Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
|
EP1945245A2
(en)
*
|
2005-11-10 |
2008-07-23 |
The Board of Control of Michigan Technological University |
Black bear parathyroid hormone and methods of using black bear parathyroid hormone
|
US20070168041A1
(en)
*
|
2006-01-17 |
2007-07-19 |
Sudhakar Kadiyala |
Method and instruments for intervertebral disc augmentation through a pedicular approach
|
LT3345607T
(lt)
*
|
2006-12-29 |
2023-01-10 |
Ossifi-Mab Llc |
Kaulų augimo keitimo būdai, skiriant sost arba wise antagonistą ar agonistą
|
CN101711168B
(zh)
|
2007-04-13 |
2013-05-01 |
库罗斯生物外科股份公司 |
聚合物组织封闭剂
|
US8241363B2
(en)
*
|
2007-12-19 |
2012-08-14 |
Depuy Spine, Inc. |
Expandable corpectomy spinal fusion cage
|
US8241294B2
(en)
*
|
2007-12-19 |
2012-08-14 |
Depuy Spine, Inc. |
Instruments for expandable corpectomy spinal fusion cage
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8876905B2
(en)
*
|
2009-04-29 |
2014-11-04 |
DePuy Synthes Products, LLC |
Minimally invasive corpectomy cage and instrument
|
JP2013512688A
(ja)
|
2009-12-07 |
2013-04-18 |
ミシガン テクノロジカル ユニバーシティ |
クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
|
BR112012026098A2
(pt)
*
|
2010-04-16 |
2016-11-22 |
Novartis Ag |
métodos e composições para melhorar a osseointegração de implante.
|
ES2882852T3
(es)
|
2011-03-16 |
2021-12-02 |
Kuros Biosurgery Ag |
Formulación farmacéutica para la utilización en la fusión espinal
|
JP6683628B2
(ja)
*
|
2014-06-04 |
2020-04-22 |
シーダーズ−サイナイ メディカル センター |
脊椎圧迫骨折の非外科的修復のための方法
|
GB2590692A
(en)
*
|
2019-12-24 |
2021-07-07 |
Corthotec Ltd |
Composition for improved bone fracture healing
|